Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Plerixafor. Nitrosamines are part of a broader class of compounds known as N-nitroso compounds.
Plerixafor, a bicyclam derivative, serves a pivotal role in hematopoietic stem cell mobilization for transplantation. By acting as a selective antagonist of the CXCR4 chemokine receptor, it disrupts the receptor-ligand interaction, facilitating the release of hematopoietic stem cells from the bone marrow into the bloodstream. This mobilization is essential for collecting stem cells needed in transplantation procedures, particularly for individuals with conditions such as multiple myeloma and non-Hodgkin lymphoma. Plerixafors chemical structure is designed to selectively target the CXCR4 receptor, demonstrating its precision in the process of optimizing stem cell yield during apheresis when used in combination with granulocyte-colony stimulating factor (G-CSF). The strategic application of plerixafor underscores its significance in enhancing the efficacy of hematopoietic stem cell transplantation for various medical conditions.
Buy high quality N-Nitroso Plerixafor Impurity 4 from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of N-Nitroso Plerixafor Impurity 4

N-Nitroso Plerixafor Impurity 4

CAT. No. CP-P68004
CAS. No. NA
Mol. F. C28H53N9O
Mol. Wt. 531.79
Stock Status Please Enquire
VIEW COA Sample PDF

Product Description


  • Category:Impurity Standards
  • Synonyms:NA
  • Chemical Name:1-(4-((1,4,8,11-Tetraazacyclotetradecan-1-yl)methyl)benzyl)-4-nitroso-1,4,8,11-tetraazacyclotetradecane

Request for Quotation : N-Nitroso Plerixafor Impurity 4

Please enter pack size
Please enter quantity
Please enter phone number
Enter 10 digit contact number
Enter only number
Please enter your full name
Please enter only alphabets
Please enter company name
Please enter your valid email
Please enter your valid email id
Please select country
Please select state
Please select city

Please select captcha
Please wait...